• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom.新冠大流行的成本:英国假设抑制政策的探索性经济评估。
Value Health. 2020 Nov;23(11):1432-1437. doi: 10.1016/j.jval.2020.07.001. Epub 2020 Aug 27.
2
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.根据潜在疾病和年龄估计与 COVID-19 大流行相关的超额 1 年死亡率:一项基于人群的队列研究。
Lancet. 2020 May 30;395(10238):1715-1725. doi: 10.1016/S0140-6736(20)30854-0. Epub 2020 May 12.
3
Cost-effectiveness and return on investment of protecting health workers in low- and middle-income countries during the COVID-19 pandemic.在 COVID-19 大流行期间保护中低收入国家卫生工作者的成本效益和投资回报。
PLoS One. 2020 Oct 9;15(10):e0240503. doi: 10.1371/journal.pone.0240503. eCollection 2020.
4
Impact of SARS-CoV2 (Covid-19) on dental practices: Economic analysis.SARS-CoV2(新冠病毒)对牙科实践的影响:经济分析。
J Dent. 2020 Aug;99:103387. doi: 10.1016/j.jdent.2020.103387. Epub 2020 May 27.
5
Providing care for the 99.9% during the COVID-19 pandemic: How ethics, equity, epidemiology, and cost per QALY inform healthcare policy.在新冠疫情期间为99.9%的人提供护理:伦理、公平、流行病学以及每质量调整生命年成本如何为医疗政策提供信息。
Healthc Manage Forum. 2020 Sep;33(5):239-242. doi: 10.1177/0840470420939854. Epub 2020 Jul 8.
6
Health Care Policy After the COVID-19 Pandemic.新冠疫情后的医疗保健政策。
JAMA. 2020 Jul 21;324(3):233-234. doi: 10.1001/jama.2020.10777.
7
UK policy targeting obesity during a pandemic - the right approach?英国在大流行期间针对肥胖问题的政策——正确的方法吗?
Nat Rev Endocrinol. 2020 Nov;16(11):609. doi: 10.1038/s41574-020-00420-x.
8
Effect of school closures on mortality from coronavirus disease 2019: old and new predictions.学校关闭对 2019 年冠状病毒病死亡率的影响:旧的和新的预测。
BMJ. 2020 Oct 7;371:m3588. doi: 10.1136/bmj.m3588.
9
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.抗病毒治疗在大流行和呼吸道疾病(包括 COVID-19)暴发中的成本效益:已发表经济评估的系统综述。
Value Health. 2020 Nov;23(11):1409-1422. doi: 10.1016/j.jval.2020.07.002. Epub 2020 Sep 6.
10
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times.COVID-19 大流行期间高健康素养患者的家庭过敏原免疫治疗的健康和经济结果:特殊时期的成本效益分析。
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2310-2321.e4. doi: 10.1016/j.jaip.2020.05.007. Epub 2020 May 14.

引用本文的文献

1
Granular Insights:A Wastewater-Based Machine Learning Approach for Localized COVID-19 Hospitalization Forecasting.粒度洞察:一种基于废水的机器学习方法用于局部地区新冠肺炎住院预测。
medRxiv. 2025 Jun 26:2025.06.25.25330294. doi: 10.1101/2025.06.25.25330294.
2
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey.新冠疫情早期阶段新冠病毒感染状况与经济成本之间的关联:来自英国症状监测数字调查的证据
Pharmacoecon Open. 2025 Mar;9(2):231-245. doi: 10.1007/s41669-024-00544-0. Epub 2024 Nov 28.
3
Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.呼吸道病原体症状传播的流行病学和健康经济学意义:一项数学建模研究。
PLoS Comput Biol. 2024 May 3;20(5):e1012096. doi: 10.1371/journal.pcbi.1012096. eCollection 2024 May.
4
Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review.COVID-19 大流行的成本与欧盟/英国/经合组织缓解策略的成本效益:系统评价。
BMJ Open. 2023 Oct 31;13(10):e077602. doi: 10.1136/bmjopen-2023-077602.
5
The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model.利用 SIR 模型研究医疗创新对美国新冠疫情相关政策成本效益的影响。
BMC Health Serv Res. 2023 Apr 18;23(1):372. doi: 10.1186/s12913-023-09282-1.
6
Cost-effectiveness analysis of vaccination against COVID-19 in China.中国 COVID-19 疫苗接种的成本效益分析。
Front Public Health. 2023 Mar 7;11:1037556. doi: 10.3389/fpubh.2023.1037556. eCollection 2023.
7
Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study.使用侧向流动设备对无症状 SARS-CoV-2 感染进行全区域检测试点的成本效益:建模和经济分析研究。
BMC Health Serv Res. 2022 Sep 22;22(1):1190. doi: 10.1186/s12913-022-08511-3.
8
State-controlled epidemic in a game against a novel pathogen.国家控制疫情应对新型病原体。
Sci Rep. 2022 Sep 20;12(1):15716. doi: 10.1038/s41598-022-19691-7.
9
Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.模拟澳大利亚维多利亚州新冠疫情政策对社会限制和封锁措施的反应与健康调整生命年和成本的关系。
JAMA Health Forum. 2021 Jul 30;2(7):e211749. doi: 10.1001/jamahealthforum.2021.1749. eCollection 2021 Jul.
10
Economic evaluations of interventions against viral pandemics: a scoping review.干预病毒性大流行的经济评估:范围综述。
Public Health. 2022 Jul;208:72-79. doi: 10.1016/j.puhe.2022.05.001. Epub 2022 Jun 17.

本文引用的文献

1
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
2
Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand".评 Ferguson 等人的“减少 COVID-19 死亡率和医疗需求的非药物干预(NPIs)的影响”一文。
Bull Math Biol. 2020 Apr 8;82(4):52. doi: 10.1007/s11538-020-00726-x.
3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
A mathematical model for simulating the phase-based transmissibility of a novel coronavirus.一种用于模拟新型冠状病毒基于相位的传染性的数学模型。
Infect Dis Poverty. 2020 Feb 28;9(1):24. doi: 10.1186/s40249-020-00640-3.
5
Transparency in Decision Modelling: What, Why, Who and How?透明度决策模型:是什么、为什么、谁和如何?
Pharmacoeconomics. 2019 Nov;37(11):1355-1369. doi: 10.1007/s40273-019-00819-z.
6
Does unemployment contribute to poorer health-related quality of life among Swedish adults?失业是否会导致瑞典成年人健康相关生活质量下降?
BMC Public Health. 2019 Apr 29;19(1):457. doi: 10.1186/s12889-019-6825-y.
7
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.在英国,初始抗生素治疗失败后对重症监护肺炎进行治疗:比较美罗培南与哌拉西林/他唑巴坦的成本-效用分析。
Eur J Health Econ. 2012 Apr;13(2):181-92. doi: 10.1007/s10198-011-0296-0. Epub 2011 Jan 18.
8
The social value of a QALY: raising the bar or barring the raise?QALY 的社会价值:提高标准还是禁止提高?
BMC Health Serv Res. 2011 Jan 11;11:8. doi: 10.1186/1472-6963-11-8.
9
Populating an economic model with health state utility values: moving toward better practice.用健康状态效用值填充经济模型:迈向更好的实践。
Value Health. 2010 Aug;13(5):509-18. doi: 10.1111/j.1524-4733.2010.00700.x. Epub 2010 Mar 10.
10
The possible macroeconomic impact on the UK of an influenza pandemic.流感大流行对英国可能产生的宏观经济影响。
Health Econ. 2010 Nov;19(11):1345-60. doi: 10.1002/hec.1554.

新冠大流行的成本:英国假设抑制政策的探索性经济评估。

Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom.

机构信息

ZALA PRMA Limited, Warrington, UK.

Department of Health Policy, Cowdray House, London School of Economics and Political Science, London, UK.

出版信息

Value Health. 2020 Nov;23(11):1432-1437. doi: 10.1016/j.jval.2020.07.001. Epub 2020 Aug 27.

DOI:10.1016/j.jval.2020.07.001
PMID:33127013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833705/
Abstract

OBJECTIVE

This study aims to cost and calculate the relative cost-effectiveness of the hypothetical suppression policies found in the Imperial College COVID-19 Response Team model.

METHODS

Key population-level disease projections in deaths, intensive care unit bed days, and non-intensive care unit bed days were taken from the Imperial College COVID-19 Response Team report of March 2020, which influenced the decision to introduce suppression policies in the United Kingdom. National income loss estimates were from a study that estimated the impact of a hypothetical pandemic on the UK economy, with sensitivity analyses based on projections that are more recent. Individual quality-adjusted life-year (QALY) loss and costed resource use inputs were taken from published sources.

RESULTS

Imperial model projected suppression polices compared to an unmitigated pandemic, even with the most pessimistic national income loss scenarios under suppression (10%), give incremental cost-effectiveness ratios below £50 000 per QALY. Assuming a maximum reduction in national income of 7.75%, incremental cost-effectiveness ratios for Imperial model projected suppression versus mitigation are below 60 000 per QALY.

CONCLUSIONS

Results are uncertain and conditional on the accuracy of the Imperial model projections; they are also sensitive to estimates of national income loss. Nevertheless, it would be difficult to claim that the hypothetical Imperial model-projected suppression policies are obviously cost-ineffective relative to the alternatives available. Despite evolving differences between government policy and Imperial model-projected suppression policy, it is hoped this article will provide some early insight into the trade-offs that are involved.

摘要

目的

本研究旨在对帝国理工学院 COVID-19 应对小组模型中发现的假设抑制政策进行成本计算和相对成本效益分析。

方法

从帝国理工学院 COVID-19 应对小组 2020 年 3 月的报告中获取关键的人群疾病死亡、重症监护病房床位天数和非重症监护病房床位天数预测数据,这些数据影响了英国实施抑制政策的决策。国家收入损失估计来自一项估计假设大流行对英国经济影响的研究,敏感性分析基于更近期的预测。个体质量调整生命年(QALY)损失和成本资源使用投入取自已发表的资料。

结果

帝国模型预测的抑制政策与未缓解的大流行相比,即使在抑制政策下(10%)最悲观的国家收入损失情景下,增量成本效益比仍低于每 QALY5 万英镑。假设国家收入最大减少 7.75%,帝国模型预测的抑制与缓解相比,增量成本效益比低于每 QALY6 万英镑。

结论

结果不确定,取决于帝国模型预测的准确性;也取决于国家收入损失的估计。尽管如此,要声称假设的帝国模型预测的抑制政策相对于可用的替代方案明显没有成本效益,这将是困难的。尽管政府政策和帝国模型预测的抑制政策之间存在不断演变的差异,但希望本文能为所涉及的权衡提供一些早期的见解。